Results 181 to 190 of about 161,156 (227)
Some of the next articles are maybe not open access.

Acute ST-elevation myocardial infarction

Current Opinion in Critical Care, 2012
Acute ST-elevation myocardial infarction (STEMI) is a major cause of morbidity, mortality, and disability. This review summarizes recent advances in the treatment of patients with STEMI.The best prehospital and interhospital transfer strategy for patients with STEMI is rapid transport to a percutaneous coronary intervention (PCI) center by Emergency ...
Eric R, Bates, Daniel S, Menees
openaire   +2 more sources

Asymptomatic ST elevation myocardial infarction

Heart & Lung, 2018
A 71-year-old non-smoking female with a history of diabetes, hypertension, hyperlipidemia and end-stage renal disease presented to the emergency department for right leg pain due to an ankle fracture.The patient's initial electrocardiogram (ECG) revealed ST segment elevations in the anterior leads.
Kenton L. Anderson   +3 more
openaire   +2 more sources

Anticoagulation in ST-Elevation Myocardial Infarction

Interventional Cardiology Clinics, 2021
Intravenous anticoagulation is standard of care in the treatment of ST-elevation myocardial infarction. Primary percutaneous coronary intervention is the most common reperfusion strategy. Four anticoagulant options are available: unfractionated heparin, enoxaparin, fondaparinux, and bivalirudin.
Chirag, Bavishi, J Dawn, Abbott
openaire   +2 more sources

Ticagrelor in ST-Elevation Myocardial Infarction

Current Vascular Pharmacology, 2012
Ticagrelor is a new oral antagonist of the platelet P2Y₁₂ receptor that offers several potential advantages compared to clopidogrel including faster and more effective inhibition of platelet aggregation. Ticagrelor has been compared to clopidogrel in the PLATelet inhibition and patient Outcomes (PLATO) trial in a broad population of patients with acute
Sgueglia GA   +2 more
openaire   +3 more sources

ACUTE ST-ELEVATION MYOCARDIAL INFARCTION

Acta Clinica Belgica, 2006
Acute ST-elevation myocardial infarction (STEMI) remains the leading cause of death in industrialized countries. For many patients, a myocardial infarction is the first presentation of atherosclerotic coronary artery disease. This often results in delays in obtaining medical attention and subsequently poorer outcome, certainly because symptoms are ...
openaire   +2 more sources

Treatment of ST-elevation Myocardial Infarction

Future Cardiology, 2008
In patients with ST-segment elevation myocardial infarction (STEMI), timely and adequate treatment may improve the prognosis dramatically. Restoration of the infarct vessel patency is one of the cornerstones of initial treatment. Compared with fibrinolytic therapy, primary percutaneous coronary intervention (PCI) results in improved short- and long ...
Rik, Hermanides, Jan Paul, Ottervanger
openaire   +2 more sources

[Echocardiography in ST-elevation myocardial infarction].

Giornale italiano di cardiologia (2006), 2018
Echocardiography is an imaging technique of paramount importance for the management of patients with ST-elevation myocardial infarction. In particular, this technique may be useful for diagnosis and is essential for prognosis and to guide drug therapy.
Mele, Donato   +5 more
openaire   +2 more sources

Transradial Intervention in ST Elevation Myocardial Infarction

Current Cardiology Reports, 2015
Primary percutaneous coronary intervention (PPCI) in ST elevation myocardial infarction (STEMI) represents the current gold standard reperfusion therapy. Recent advances in antiplatelet and anticoagulant therapy have reduced the risk of ischemic complications and mortality in PPCI although this has been at the expense of major bleeding complications ...
Mustafa, Ahmad H S   +6 more
openaire   +2 more sources

ST elevation: differentiation between ST elevation myocardial infarction and nonischemic ST elevation

Journal of Electrocardiology, 2011
It is well accepted that early reperfusion is beneficial in patients with acute myocardial infarction presenting with ST elevation (STE). Earlier studies suggested lack of beneficial effects in patients presenting without STE and even with ST depression.
Henry D, Huang, Yochai, Birnbaum
openaire   +2 more sources

Biomarkers and ST-elevation myocardial infarction

Heart, 2013
In the recent Heart paper, Cuculi et al 1 from Oxford University challenge two conventional wisdoms in clinical cardiology: first, biomarkers do not have a role in the management of patients presenting with suspected ST-elevation myocardial infarction (STEMI); and second, in the absence of cardiogenic shock, there is no remaining unmet clinical need in
openaire   +2 more sources

Home - About - Disclaimer - Privacy